NFC Authentication Adoption Keeps Steadily Expanding
Pharmaceutical manufacturers and luxury brand owners are expanding NFC-enabled authentication beyond flagship products into broader product lines, driven by rising counterfeit-liability exposure and consumer expectation for tap-to-verify functionality at the point of purchase. This shift is pulling connected packaging out of premium-only niches and into mainstream consumer packaged goods lines faster than converters anticipated two years ago. Suppliers able to demonstrate reliable chip integration at commodity price points are winning disproportionate new contract volume across multiple product categories simultaneously this cycle, a pattern now visible across most major pharmaceutical markets. Much of this also feeds into the smart tag packaging market, which MMA expects to grow at 8.4% a year through 2036.
Market Impact: Avoids up to 16% counterfeit loss








